Global market leader in chemicals and ingredients distribution, Brenntag has recently announced the signing of a distribution agreement with Aker BioMarine, covering health supplements such as Superba 2, Superba 2 Halal, Superba Boost, and Antarctic Krill Oil 2.
Read: April Issue of Food Infotech Magazine.
Aker BioMarine is a biotech innovator and Antarctic krill harvesting company dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant and to customers around the world.
Superba Krill oil, an Aker BioMarine product is a next-generation phospholipid-complex with omega-3s and choline. The natural combination of multiple nutrients offers a wide range of clinically proven health benefits to match the needs of health-conscious consumers. Powered by phospholipids, Superba Krill ensures that omega-3s EPA & DHA and choline are delivered to parts of the body that need them the most, such as the brain, heart, eyes and liver. Superba Krill oil is pure, sustainable and traceable, backed by more than 50 human studies.
“We are thrilled to announce our strategic partnership with Brenntag Specialties, marking a significant step forward in our mission to serve the nutraceutical segment in Southeast Asia. This distribution agreement underscores our commitment to providing high-quality, sustainable Antarctic Krill oil products to customers in the region. Through this collaboration, we aim to enhance human health and well-being by offering innovative solutions backed by scientific research. We look forward to leveraging Brenntag’s extensive network and expertise to bring our products to a broader audience and make a positive impact on the health and vitality of consumers across Southeast Asia.”
Ross Norris, General Manager Asia Pacific, Aker BioMarine.
“We are delighted to enter this strategic partnership with Aker BioMarine which sets sustainability and health at the heart of their values. Aker BioMarine solutions are innovative, clinically proven, and have multiple health benefits and we will use all our expertise and capabilities to bring these complementary solutions to our customers and consumers across Southeast Asia. This agreement reinforces Brenntag Specialties’ complementary medicines offering in Southeast Asia and affirms our focus on pharmaceutical and nutraceutical solutions across the APAC region.”
Romain Girard, Regional President, Pharma Asia Pacific, Brenntag Specialties.
Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,700 employees worldwide and operates a network of about 600 sites in 72 countries. In 2023, Brenntag generated sales of 16.8 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its sector and the industries served.